Several government agencies are investigating the production of an injectable steroid that was shipped to clinics in parts of North Carolina, including a medical center in Brunswick County. This comes after the FDA learned of two people who developed complications after taking the product.
The injectable steroid product, called methylprednisolone acetate, was prepared by the Main Street Family Pharmacy of Newbern, Tennessee. It was shipped to three clinics in North Carolina -- Carolina Arthritis Center in Pitt County, Bailey Family Practice Center in Nash County, and Shallotte Medical Center in Brunswick County.
Main Street has issued a voluntary recall for all sterile products.
According to a news release, state and local public health officials are working with those clinics to notify patients who may have taken the product and alert them to any complications. The NC Board of Pharmacy asked that the steroid be quarantined and each pharmacy has agreed to voluntarily surrender their state pharmacy licenses.
The complications that have been identified at this point are for skin abscesses. There have been no reports of meningitis, stroke or death, according to the notification.
The complications were noted by people who administered the product at a clinic in Greenville, NC, according to a news release.
